Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Help Your Business with Master Web based Promoting Arrangements - 2Cuba fights to contain spread of mosquito-borne chikungunya virus
- 3Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- 4RSF attack on Sudan’s South Kordofan kills at least 14, including children
- 5Europe must reinvent warfare for ‘era of shocks,’ NATO’s Vandier says
- Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- New studies of old dogs help scientists understand where they came from
- Danish warship sunk by famed British admiral discovered after 225 years
- 5 High Limit Outer Hard Drives For Information Stockpiling
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Manual for Tracking down the Mysterious Cascades in China
- SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video)
- Holiday destinations for Creature Sweethearts
- Alice Wong, founder of the Disability Visibility Project, dies at 51
